ミシガン州における結腸癌の臨床試験
ミシガン州内の拠点で、結腸癌に関する18件の研究が参加者を募集しています。
ミシガン州内の都市
- Grand Rapids11件の研究
- Ann Arbor7件の研究
- Detroit6件の研究
- Wyoming5件の研究
- Lansing4件の研究
- Muskegon4件の研究
- Kalamazoo4件の研究
- Livonia3件の研究
- Flint3件の研究
- Saginaw3件の研究
- Warren3件の研究
- Canton3件の研究
- Waterford3件の研究
- Clinton Township3件の研究
公式研究テキスト（英語）
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
- 他50件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07283939Family Communications After Genetic Testing
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- 他48件
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/02更新 · NCT07143487A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
- ALX Center 8, Farmington Hills
- ALX Center 3, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07085091Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- The Cancer & Hematology Centers, Big Rapids
- The Cancer & Hematology Centers, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- START Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/21更新 · NCT07629960A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- GSK Investigational Site, Detroit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07213609A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Trinity Health St Joseph Mercy Ann Arbor, Ann Arbor
- Henry Ford Hospital, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07284849ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Bronson Battle Creek, Battle Creek
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- 他12件
被験者募集中
45歳〜70歳 · 全性別 · 2026/09/02更新 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- 他47件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05174169A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- START Midwest, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07321106Shield Post-Approval Study Protocol
- Embassy Research Network, Bloomfield Township
被験者募集中観察研究健康なボランティア歓迎
45歳〜81歳 · 全性別 · 2026/08/07更新 · NCT06880055A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- START Midwest, LLC, Grand Rapids
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT07318805Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- University of Michigan, Ann Arbor
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/11更新 · NCT00843375Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Midwest, Grand Rapids
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/02/17更新 · NCT07145255Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Detroit
被験者募集中第3相
18歳以上 · 全性別 · 2026/01/23更新 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。